Oragenics Enters into Licensing Agreement with the National Research Council of Canada, to Pursue the Rapid Development of Next-Generation SARS-CoV-2 Vaccines
Stock Information for Oragenics Inc.
Loading
Please wait while we load your information from QuoteMedia.